Online edition of India's National Newspaper
Wednesday, Jan 07, 2009
ePaper | Mobile/PDA Version
Google

Business
News: ePaper | Front Page | National | Tamil Nadu | Andhra Pradesh | Karnataka | Kerala | New Delhi | Other States | International | Opinion | Business | Sport | Miscellaneous | Engagements |
Advts: Retail Plus | Classifieds | Jobs | Obituary |



Business - Briefly Printer Friendly Page   Send this Article to a Friend

Health Canada nod for Aurobindo Pharma

HYDERABAD: Aurobindo Pharma has received approval for its Abbreviated New Drug Submission (ANDS) Gabapentin capsules 100 mg, 300 mg and 400 mg from Health Canada. This is Aurobindo Pharma’s sixth product approval from Health Canada, according to a company release. This drug is indicated for treatment of seizures in patients diagnosed with epilepsy. — Special Correspondent

Printer friendly page  
Send this article to Friends by E-Mail

Business

News: ePaper | Front Page | National | Tamil Nadu | Andhra Pradesh | Karnataka | Kerala | New Delhi | Other States | International | Opinion | Business | Sport | Miscellaneous | Engagements |
Advts: Retail Plus | Classifieds | Jobs | Obituary | Updates: Breaking News |


News Update

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | Publications | eBooks | Images | Ergo | Home |

Copyright © 2009, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu